NCT00141960View on ClinicalTrials.gov

Famotidine in Subjects With Non-erosive Gastroesophageal Reflux Disease

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

480

Participants

Timeline

Start Date

September 30, 2005

Conditions
Gastroesophageal Reflux
Interventions
DRUG

Famotidine

Trial Locations (7)

Unknown

Hokkaido Region

Kanto Region

Kinki Region

Kyushu Region

Shikoku Region

Tohoku Region

Tokai Region

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY